Barrington Research Reiterates Market Perform Rating for LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report)'s stock had its "market perform" rating reissued by analysts at Barrington Research in a report released on Tuesday,Benzinga reports.

LeMaitre Vascular Price Performance

NASDAQ LMAT traded up $0.57 on Tuesday, hitting $80.39. The stock had a trading volume of 109,287 shares, compared to its average volume of 168,891. The firm has a 50-day moving average of $82.76 and a 200-day moving average of $87.63. The company has a debt-to-equity ratio of 0.48, a quick ratio of 13.83 and a current ratio of 16.49. LeMaitre Vascular has a 52-week low of $71.42 and a 52-week high of $109.58. The company has a market capitalization of $1.82 billion, a price-to-earnings ratio of 40.60, a price-to-earnings-growth ratio of 2.11 and a beta of 0.82.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 EPS for the quarter, missing analysts' consensus estimates of $0.50 by ($0.02). LeMaitre Vascular had a return on equity of 13.53% and a net margin of 19.96%. The company had revenue of $59.87 million during the quarter, compared to analysts' expectations of $57.61 million. During the same period in the prior year, the firm earned $0.44 EPS. LeMaitre Vascular's quarterly revenue was up 12.0% on a year-over-year basis. Equities analysts expect that LeMaitre Vascular will post 1.94 EPS for the current year.

Insider Buying and Selling at LeMaitre Vascular

In other news, CEO George W. Lemaitre sold 76,868 shares of the business's stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $85.79, for a total value of $6,594,505.72. Following the sale, the chief executive officer directly owned 1,796,783 shares of the company's stock, valued at $154,146,013.57. The trade was a 4.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In the last quarter, insiders sold 100,000 shares of company stock worth $8,556,857. 9.50% of the stock is currently owned by corporate insiders.

Institutional Trading of LeMaitre Vascular

Institutional investors and hedge funds have recently modified their holdings of the business. Summit Investment Advisors Inc. boosted its holdings in shares of LeMaitre Vascular by 8.2% in the fourth quarter. Summit Investment Advisors Inc. now owns 2,122 shares of the medical instruments supplier's stock worth $196,000 after buying an additional 160 shares during the last quarter. HighTower Advisors LLC increased its holdings in LeMaitre Vascular by 3.9% during the fourth quarter. HighTower Advisors LLC now owns 5,683 shares of the medical instruments supplier's stock valued at $524,000 after buying an additional 212 shares during the last quarter. Bank of Montreal Can raised its position in LeMaitre Vascular by 8.3% in the fourth quarter. Bank of Montreal Can now owns 2,926 shares of the medical instruments supplier's stock worth $270,000 after acquiring an additional 223 shares during the period. Avantax Advisory Services Inc. boosted its stake in shares of LeMaitre Vascular by 1.5% during the 1st quarter. Avantax Advisory Services Inc. now owns 15,035 shares of the medical instruments supplier's stock worth $1,261,000 after acquiring an additional 229 shares during the last quarter. Finally, Harbor Capital Advisors Inc. grew its position in shares of LeMaitre Vascular by 1.1% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 22,282 shares of the medical instruments supplier's stock valued at $1,851,000 after acquiring an additional 245 shares during the period. Institutional investors own 84.64% of the company's stock.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.